跳至主要内容
临床试验/NCT03599076
NCT03599076Unknown不适用

Wearable Sensors for Quantitative Assessment of Motor Impairment in Huntington's Disease

BioSensics1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2018年9月25日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
50
试验地点
1
主要终点
Chorea severity score

研究概览

简要总结

The principal means of measuring motor impairment in Huntington disease (HD) is the Unified Huntington's Disease Rating Scale (UHDRS) total motor score, which is subjective, categorical, requires significant training to administer correctly, and only captures impairments in clinic. In this Direct to Phase II SBIR we will develop a wearable sensor system for objective, sensitive, and continuous assessment of Huntington's chorea during activities of daily living. The developed technology could be used clinically to detect changes in motor function in response to medications, or could be used scientifically to expedite and reduce the cost of early stage pharmaceutical clinical trials.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • CAG expansion ≥ 36

排除标准

  • 未提供

结局指标

主要结局

Chorea severity score

时间窗: 12 months

Remotely monitored chorea severity score based on movement data during activities of daily living

次要结局

未报告次要终点

研究者

发起方
BioSensics
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验